Summary
- Current Price
- As of today, ALLO price is $1.99, down -0.75% on
- Current Price All-Time High
- ALLO price is currently -96.39% below its historical high of $55.00 set on
- Market Cap
- ALLO current market cap is $686M, up +178.16% over the past 365 days
- Revenue
- ALLO current annual revenue is $0.00, down -100.00% year-over-year
- Next Earnings
- The next earnings release for ALLO is on
Profile
| Metric | Value |
|---|---|
| Full Name | Allogene Therapeutics, Inc. |
| Ticker | NASDAQ: ALLO |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | allogene.com |
| Employees | 226 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $1.99 | |
| Price, 1D Change | -0.75% | |
| $686M | ||
| - | ||
| - | ||
| 2.17 | ||
| $0.00 | ||
| Revenue, 1Y Change | -100.00% | |
| -$0.87 | ||
| EPS, 1Y Change | +34.56% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.87 | ||
| EPS Estimate | -$0.59 | N/A |
| EPS Est. Change | +32.24% | N/A |
| $0.00 | ||
| Revenue Estimate | $3.40M | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $1.99 | |
| Price Target | $9.00 | - |
| Price Tgt. Change | +353.40% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.32 | -$1.32 | +0.20% | |
| -$0.91 | -$0.87 | +4.76% | |
| -$0.59 | N/A | +32.24% | |
| -$0.70 | N/A | +18.84% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $34.29K | $22.00K | -35.84% | |
| $1,670.00 | $0.00 | -100.00% | |
| $3.40M | N/A | - | |
| $12.09M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $1.99 | |
| $1.96 | ||
| $1.99 | ||
| $1.95 | ||
| $2.01 | ||
| $0.02 | ||
| 2.17 | ||
| $0.12 | ||
| 47.85 | ||
| 82.25% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$0.87 | ||
| -$12.36M | ||
| - | ||
| -$206.93M | ||
| - | ||
| -$190.89M | ||
| - | ||
| -$194.57M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.28 | ||
| 7.93 | ||
| 7.93 | ||
| - | ||
| - | ||
| -4.42 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 147.80 | ||
| 1.57 | ||
| -2.56 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $292.54M | ||
| $250.21M | ||
| $415.91M | ||
| $257.75M | ||
| $123.36M | ||
| $32.51M | ||
| $83.25M | ||
| $8.21M | ||
| $4.27M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $190.89M | ||
| $194.57M | ||
| $12.36M | ||
| $0.00 | ||
| $12.36M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$149.25M | ||
| $95.56M | ||
| $30.16M | ||
| $386.00K | ||
| -$149.63M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Citizens | → | |
| JP Morgan | → | |
| HC Wainwright & Co. | → | |
| Jefferies | → | |
| HC Wainwright & Co. | → | |
| Citizens | → | |
| Bernstein | → | |
| Baird | → | |
| Argus Research | → | |
| Piper Sandler | → |
Analyst sentiment
Institutional ownership
Screeners with ALLO
FAQ
- What is the ticker symbol for Allogene Therapeutics, Inc.?
- The ticker symbol for Allogene Therapeutics, Inc. is NASDAQ:ALLO
- Does Allogene Therapeutics, Inc. pay dividends?
- No, Allogene Therapeutics, Inc. does not pay dividends
- What sector is Allogene Therapeutics, Inc. in?
- Allogene Therapeutics, Inc. is in the Healthcare sector
- What industry is Allogene Therapeutics, Inc. in?
- Allogene Therapeutics, Inc. is in the Biotechnology industry
- What country is Allogene Therapeutics, Inc. based in?
- Allogene Therapeutics, Inc. is headquartered in United States
- When did Allogene Therapeutics, Inc. go public?
- Allogene Therapeutics, Inc. initial public offering (IPO) was on October 11, 2018
- Is Allogene Therapeutics, Inc. in the S&P 500?
- No, Allogene Therapeutics, Inc. is not included in the S&P 500 index
- Is Allogene Therapeutics, Inc. in the NASDAQ 100?
- No, Allogene Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Allogene Therapeutics, Inc. in the Dow Jones?
- No, Allogene Therapeutics, Inc. is not included in the Dow Jones index
- When was Allogene Therapeutics, Inc. last earnings report?
- Allogene Therapeutics, Inc.'s most recent earnings report was on August 12, 2026
- When does Allogene Therapeutics, Inc. report earnings?
- The next expected earnings date for Allogene Therapeutics, Inc. is November 5, 2026
Data Sources & References
- ALLO Official Website allogene.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1737287/000162828026017242/0001628280-26-017242-index.htm
- ALLO Profile on Yahoo Finance finance.yahoo.com/quote/ALLO
- ALLO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/allo